Intestinal peptide transport systems and oral drug availability

Pharmaceutical Research

Volumn 16, Issue 9, 1999, Pages 1331-1343

  Yang, Cheng Y ^a   Dantzig, Anne H ^b   Pidgeon, Charles ^a  

^a PURDUE UNIVERSITY   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Drug absorption; HPT 1; Intestine; PepT1; PepT2; Peptide transport; PHT 1

Indexed keywords

ACICLOVIR; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AMINO ACID; AMOXICILLIN; AMPICILLIN; BESTATIN; BETA LACTAM ANTIBIOTIC; CARBOXYL GROUP; CARNOSINE; CARRIER PROTEIN; CEFACLOR; CEFADROXIL; CEFALEXIN; CEFATRIZINE; CEFIXIME; CEFRADINE; CERANAPRIL; CYCLACILLIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LISINOPRIL; MESSENGER RNA; METHYLDOPA; PEPTIDE; PROTIRELIN; PROTIRELIN DERIVATIVE; RENIN INHIBITOR; THROMBIN INHIBITOR; UNINDEXED DRUG; VALACICLOVIR;

BRAIN; CARBOXY TERMINAL SEQUENCE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; GENE; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTESTINE ABSORPTION; KIDNEY EPITHELIUM; MOLECULAR CLONING; NONHUMAN; ORAL DRUG ADMINISTRATION; PLACENTA; PRIORITY JOURNAL; RETINA; REVIEW; SMALL INTESTINE;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; CARRIER PROTEINS; DIETARY PROTEINS; HUMANS; INTESTINAL ABSORPTION; INTESTINES; PEPTIDES; SYMPORTERS;

EID: 0032853619     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018982505021     Document Type: Review

References (118)

1. A. H. Dantzig, D. C. Duckworth, and L. B. Tabas. Transport mechanisms responsible for the absorption of Ioracarbef, cefixime, and cefuroxime axetil into human intestinal Caco-2 cells. Biochim. Biophys. Acta 1191:7-13 (1994).
2. A. H. Dantzig and L. Bergin. Carrier-mediated uptake of cephalexin in human intestinal cells. Biochem. Biophys. Res. Commun. 155:1082-7 (1988).
3. A. H. Dantzig, L. B. Tabas, and L. Bergin. Cefaclor uptake by the proton-dependent dipeptide transport carrier of human intestinal Caco-2 cells and comparison to cephalexin uptake. Biochim. Biophys. Acta 1112:167-73 (1992).
4. W. Kramer, F. Girbig, U. Gutjahr, H. W. Kleeman, I. Leipe, H. Urbach, and A. Wagner. Interaction of renin inhibitors with the intestinal uptake system for oligopeptides and beta-lactam antibiotics. Biochim. Biophys. Acta 1027:25-30 (1990).
5. D. T. Thwaites, M. Cavet, B. H. Hirst, and N. L. Simmons. Angiotensin-converting enzyme (ACE) inhibitor transport in human intestinal epithelial (Caco-2) cells. Br. J. Pharmacol. 114:981-6 (1995).
6. D. I. Friedman and G. L. Amidon. Intestinal-absorption mechanism of dipeptide angiotensin converting enzyme-inhibitors of the lysyl-proline type-lisinopril and SQ-29.852. J. Pharm. Pharmacol. 78:995-98 (1989).
7. +/dipeptide cotransport system. J. Pharmacol. Exp. Ther. 252:859-62 (1990).
8. J. M. Addison, D. Burston, J. A. Dalrymple, D. M. Matthews, J. W. Payne, M. H. Sleisenger, and S. Wilinso. A common mechanism for transport of di-and tripeptides by hamster jejunum in vitro. Clin. Sci. Mol. Med. 49:313-22 (1975).
9. M. Himukai and T. Hoshi. Mechanisms of glycyl-L-leucine uptake by guinea-pig small intestine: relative importance of intact-peptide transport. J. Physiol. 302:155-69 (1980).
10. V. Ganapathy and F. H. Leibach. Role of pH gradient and membrane potential in dipeptide transport in intestinal and renal brush-border membrane vesicles from the rabbit. Studies with L-carnosine and glycyl-L-proline. J. Biol. Chem. 258:14189-92 (1983).
11. + coupled active transport of bestatin via the dipeptide transport system in rabbit intestinal brush-border membranes. J. Pharmacol. Exp. Ther. 260:482-6 (1992).
12. E. P. Eddy, C. Wood, J. Miller, G. Wilson, and I. J. Hidalgo. A comparison of the affinities of dipeptides and antibodies for the di-/tripeptide transporter in Caco-2 cells. Int. J. Pharm. 115:79-86 (1995).
13. F. M. Ryan and P. L. Smith. Effects of altering fluid transport on the absorption of benzylpenicillin and mannitol across rat intestinal mucosa in vitro. Pharm. Res. 6:S-88 (1989).
14. C. H. Gochoco, F. M. Ryan, J. Miller, P. L. Smith, and I. J. Hidalgo. Uptake and transepithelial transport of the orally absorbed cephalosporin cephalexin in the human intestinal cell line, Caco-2. Int. J. Pharm. 104:187-202 (1994).
15. A. Tsuji. Intestinal absorption of β-lactam antibiotics, in Peptide-based drug design. Controlling transport and metabolism, M. D. Taylor and G. L. Amidon, Editors. 1995, American Chemical Society: Washington, D.C. pp. 101-34.
16. W. Kramer, F. Girbig, U. Gutjahr, and S. Kowalewski. The intestinal oligopeptide transporter: Molecular characterization and substrate specificity, in Peptide-based Drug Design, M. D. Taylor and G. L. Amidon, Editors. 1995, American Chemical Society: Washington. pp. 149-80.
17. A. Tsuji. Intestinal uptake of β-lactam antibiotics and its relationship to peptide transport. Adv. Biosci. 65:125-31 (1987).
18. M. E. Ganapathy, M. Brandsch, P. D. Prasad, V. Ganapathy, and F. H. Leibach. Differential recognition of β-lactam antibiotics by intestinal and renal peptide transporters, PEPT 1 and PEPT 2. J. Biol. Chem. 270:25672-7 (1995).
19. D. M. Oh, P. J. Sinko, and G. L. Amidon. Characterization of the oral absorption of some beta-lactams: effect of the alpha-amino side chain group. J. Pharm. Sci. 82:897-900 (1993).
20. + coupled uphill transport of aminocephalosporins via the dipeptide transport system in rabbit intestinal brush-border membranes. J. Biol. Chem. 261:14130-4 (1986).
21. N. J. Snyder, L. B. Tabas, D. M. Berry, D. C. Duckworth, D. O. Spry, and A. H. Dantzig. Structure-activity relationship of carbacephalosporins and cephalosporins: antibacterial activity and interaction with the intestinal proton-dependent dipeptide transport carrier of Caco-2 cells. Antimicrob. Agents Chemother. 41:1649-57 (1997).
22. I. Tamai, N. Tomizawa, T. Takeuchi, K. Nakayama, H. Higashida, and A. Tsuji. Functional expression of transporter for beta-lectam antibiotics and dipeptides in Xenopus laevis oocytes injected with messenger RNA from human, rat and rabbit small intestines. J. Pharmacol. Exp. Ther. 273:26-31 (1995).
23. T. Bergan. Pharmacokinetic properties of the cephalosporins. Drugs 34:89-104 (1987).
24. D. I. Friedman and G. L. Amidon. Passive and carrier-mediated intestinal absorption components of two angiotensin converting enzyme (ACE) inhibitor prodrugs in rats: enalapril and fosinopril. Pharm. Res. 6:1043-7 (1989).
25. J. S. Kim, R. L. Oberle, D. A. Krummel, J. B. Dressman, and D. Fleisher. Absorption of ACE inhibitors from small intestine and colon. J. Pharm. Sci. 83:1350-6 (1994).
26. D. A. Johnson and G. L. Amidon. Determination of intrinsic membrane transport parameters from perfused intestine experiments: A boundary layer approach to estimating the aqueous and unbiased membrane permeabilities. J. Theor. Biol. 131:93-106 (1988).
27. G. L. Amidon, P. J. Sinko, and D. Fleisher. Estimating human oral fraction dose absorption: A correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds. Pharm. Res. 5:651-4 (1988).
28. + coupled active transport of bestatin via the dipeptide transport system in rabbit intestinal brush-border membranes. J. Pharmacol. Exp. Ther. 260:482-6 (1992).
29. R. Hori, Y. Tomita, T. Katsura, M. Yasuhara, K. Inui, and M. Takano. Transport of bestatin in rat renal brush-border membrane vesicles. Biochem. Pharmacol. 45:1763-8 (1993).
30. E. Walter, T. Kissel, M. Reers, G. Dickneite, D. Hoffmann, and W. Stuber. Transepithelial transport properties of peptidomimetic thrombin inhibitors in monolayers of a human intestinal cell line (Caco-2) and their correlation to in vivo data. Pharm. Res. 12:360-5 (1995).
31. M. J. Humphrey and P. S. Ringrose. Peptides and related drugs: A review of their absorption, metabolism, and excretion. Drug Metab. Rev. 11:283-310 (1986).
32. E. C. Griffiths. Thyrotropin releasing hormone: endocrine and central effects. Psychoneuroendocrinology 10:225-35 (1985).
33. D. J. Ward, E. C. Griffiths, and B. Robson. Conformational study of thyrotrophin-releasing hormone. I. Aspects of importance in the design of novel TRH analogues. Int. J. Pept. Protein Res. 27:461-71 (1986).
34. E. C. Griffiths. Thyrotropin-releasing hormone. New applications in the clinic. Nature 322:212-3 (1986).
35. E. C. Griffiths. Clinical applications of thyrotropin-releasing hormone. Clin. Sci. 73:449-57 (1987).
36. E. Walter and T. Kissel. Transepithelial transport and metabolism of thyrotropin-releasing hormone (TRH) in monolayers of a human intestinal cell line (Caco-2): Evidence for an active transport component. Pharm. Res. 11:1575-80 (1994).
37. S. Yokohama, T. Yoshioka, K. Yamashita, and N. Kitamori. Intestinal absorption mechanism of thyrotropin-releasing hormone. J. Pharmacobiodyn. 7:445-51 (1984).
38. S. Yokohama, H. Yamashita, H. Toguchi, J. Takeuchi, and N. Kitamori. Absorption of thyrotropin-releasing hormone after oral administration of TRH tartrate monohydrate in the rat, dog and human. J. Pharmacobiodyn. 7:101-11 (1984).
39. K. Tanaka, T. Fujita, Y. Yamamoto, M. Murakami, A. Yamamoto, and S. Muranishi. Enhancement of intestinal transport of thyrotropin-releasing hormone via a carrier-mediated transport system by chemical modification with lauric acid. Biochim. Biophys. Acta 1283:119-26 (1996).
40. G. L. Amidon and H. J. Lee. Absorption of peptide and peptidomimetic drugs. Annu. Rev. Pharmacol. Toxicol. 34:321-41 (1994).
41. V. Ganapathy, M. Brandsch, and F. H. Leibach, Intestinal transport of amino acids and peptides, in Physiology of the gastrointestinal tract, L. R. Johnson, Editor. 1994, Raven Press: New York. pp. 1773-94.
42. M. Hu, P. Subramanian, H. I. Mosberg, and G. L. Amidon. Use of the peptide carrier system to improve the intestinal absorption of L-alpha-methyldopa: carrier kinetics, intestinal permeabilities, and in vitro hydrolysis of dipeptidyl derivatives of L-alpha-methyldopa. Pharm. Res. 6:66-70 (1989).
43. A. Tsuji, I. Tamai, M. Nakanishi, and G. L. Amidon. Mechanism of the absorption of the dipeptide α-methyldopa-phe in intestinal brush border membrane vesicles. Pharm. Res. 7:308-9 (1990).
44. M. A. Asgharnejad and G. L. Amidon. Improved oral delivery via the peptide transporter: a dipeptide prodrug of L-alpha-methyldopa. Pharm. Res. 9:S-248 (1992).
45. H. P. Wang, H. H. Lu, J. S. Lee, C. Y. Cheng, J. R. Mah, C. Y. Ku, W. Hsu, C. F. Yen, C. J. Lin, and H. S. Kuo. Intestinal absorption studies on peptide mimetic alpha-methyldopa prodrugs. J. Pharm. Pharmacol. 48:270-6 (1996).
46. H. K. Han, R. L. A. deVrueh, J. K. Rhie, K. M. Y. Covitz, P. L. Smith, C. P. Lee, D. M. Oh, W. Sadee, and G. L. Amidon. 5′-amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter. Pharm. Res. 15:1154-9 (1998).
47. M. E. Ganapathy, W. Huang, H. Wang, V. Ganapathy, and F. H. Leibach. Valacyclovir: A substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2. Biochem. Biophys. Res. Commun. 246:470-5 (1998).
48. W. Kramer, U. Gutjahr, F. Girbig, and I. Leipe. Intestinal absorption of dipeptides and β-lactam antibiotics. II Purification of the binding protein for dipeptides and β-lactam antibiotics from rabbit small intestinal brush border membranes. Biochim. Biophys. Acta 1030:50-9 (1990).
49. W. Kramer, F. Girbig, U. Gutjahr, S. Kowalewski, F. Adam, and W. Schiebler. Intestinal absorption of beta-lactam antibiotics and oligopeptides. Functional and stereospecific reconstitution of the oligopeptide transport system from rabbit small intestine. Eur. J. Biochem. 204:923-30 (1992).
50. +/oligopeptide transport system from rabbit small intestine. Biochim. Biophys. Acta 1373:179-94 (1998).
51. Y. Miyamoto, Y. G. Thompson, E. F. Howard, V. Ganapathy, and F. H. Leibach. Functional expression of the intestinal peptide-proton co-transporter in Xenopus laevis oocytes. J. Biol. Chem. 266:4742-5 (1991).
52. I. Tamai, N. Tomizawa, A. Kadowaki, T. Terasaki, K. Nakayama, H. Higashida, and A. Tsuji. Functional expression of intestinal dipeptide/beta-lactam antibiotic transporter in Xenopus laevis oocytes. Biochem. Pharmacol. 48:881-8 (1994).
53. H. Saito, T. Ishii, and K. Inui. Expression of human intestinal dipeptide transporter in Xenopus laevis oocytes. Biochem. Pharmacol. 45:776-9 (1993).
54. Y. J. Fei, Y. Kanai, S. Nussberger, V. Ganapathy, F. H. Leibach, M. F. Romero, S. K. Singh, W. F. Boron, and M. A. Hediger. Expression cloning of a mammalian proton-coupled oligopeptide transporter. Nature 368:563-6 (1994).
55. M. Boll, D. Markovich, W. M. Weber, H. Korte, H. Daniel, and H. Murer. Expression cloning of a cDNA from rabbit small intestine related to proton-coupled transport of peptides, betalactam antibiotics and ACE-inhibitors. Pflugers Arch. 429:146-9 (1994).
56. 6/peptide cotransporter. Cloning, functional expression, and chromosomal localization. J. Biol. Chem. 270:6456-63 (1995).
57. +/peptide cotransporter mediating absorption of β-lactam antibiotics in the intestine and kidney. J. Pharmacol. Exp. Ther. 275:1631-7 (1995).
58. K. Miyamoto, T. Shiraga, K. Morita, H. Yamamoto, H. Haga, Y. Taketani, I. Tamai, Y. Sai, A. Tsuji, and E. Takeda. Sequence, tissue distribution and developmental changes in rat intestinal oligopeptide transporter. Biochim. Biophys. Acta 1305:34-8 (1996).
59. K. M. Covitz, G. L. Amidon, and W. Sadee. Human dipeptide transporter, hPEPT1, stably transfected into Chinese hamster ovary cells. Pharm. Res. 13:1631-4 (1996).
60. +-coupled oligopeptide transporter hPEPT1. J. Biol. Chem. 271:5430-7 (1996).
61. A. K. Yeung, S. K. Basu, S. K. Wu, C. Chu, C. T. Okamoto, S. F. HammAlvarez, H. vonGrafenstein, W. C. Shen, K. J. Kim, M. B. Bolger, I. S. Haworth, D. K. Ann, and V. H. L. Lee. Molecular identification of a role for tyrosine 167 in the function of the human intestinal proton-coupled dipeptide transporter (hPepT1). Biochem. Biophys. Res. Commun. 250:103-7 (1998).
62. M. B. Bolger, I. S. Haworth, A. K. Yeung, D. Ann, H. vonGrafenstein, S. HammAlvarez, C. T. Okamoto, K. J. Kim, S. K. Basu, S. Wu, and V. H. L. Lee. Structure, function, and molecular modeling approaches to the study of the intestinal dipeptide transporter PepT1. J. Pharm. Sci. 87:1286-91 (1998).
63. F. Doring, J. Will, S. Amasheh, W. Clauss, H. Ahlbrecht, and H. Daniel. Minimal molecular determinants of substrates for recognition by the intestinal peptide transporter. J. Biol. Chem. 273:23211-8 (1998).
64. +/di-tripeptide transporter (PepT1) expression in the rabbit intestine. Pflugers Arch. 430:394-400 (1995).
65. +/peptide cotransporter family, from human kidney. Biochim. Biophys. Acta 1235:461-6 (1995).
66. D. E. Gonzalez, K.-M. Y. Covitz, W. Sadee, and R. J. Mrsny. An oligopeptide transporter is expressed at high levels in the pancreatic cancinoma cell lines AsPc-1 and Capan-2. Cancer Res. 58:519-25 (1998).
67. N. Sonenberg. mRNA translation: influence of the 5′ and 3′ untranslated regions. Curr. Opin. Genet. Dev. 4:310-5 (1994).
68. N. Standart and R. J. Jackson. Regulation of translation by specific protein/mRNA interactions. Biochimie 76:867-79 (1994).
69. K. Iseki, K. Yonemura, T. Kikuchi, I. Naasani, M. Sugawara, M. Kobayashi, N. Kohri, and K. Miyazaki. Purification by ceftibutenaffinity chromatography and the functional reconstitution of oligopeptide transporter(s) in rat intestinal brush-border membrane. Biochim. Biophys. Acta 1370:161-8 (1998).
70. +/peptide contransporter, PEPT1. Biochem. Biophys. Res. Commun. 237:577-82 (1997).
71. A. H. Dantzig, J. Haskins, L. B. Tabas, S. Bright, R. L. Shepard, L. L. Jenkins, D. C. Duckworth, R. Sportsman, D. MacKensen, P. R. Rosteck, and P. L. Skatrud. Association of intestinal peptide transport with a protein related to the cadherin superfamily. Science 264:430-3 (1994).
72. K. Hofmann and W. Stoffel. TMbase - A database of membrane spanning proteins segments. Biol. Chem. Hoppe Seyler 347:166 (1993).
73. C. Y. Yang. Studies on the human intestinal di-/tripeptide transporer HPT-1 as a potential carrier for orally administered drugs. Thesis, Purdue University, West Lafayette, Indiana (1998).
74. M. Boll, M. Herget, M. Wagener, W. M. Weber, D. Markovich, J. Biber, W. Clauss, H. Murer, and H. Daniel. Expression cloning and functional characterization of the kidney cortex high-affinity proton-coupled peptide transporter. Proc. Natl. Acad. Sci. U.S.A. 93:284-9 (1996).
75. H. Saito, T. Terada, M. Okuda, S. Sasaki, and K. Inui. Molecular cloning and tissue distribution of rat peptide transporter PEPT2. Biochim. Biophys. Acta 1280:173-7 (1996).
76. F. Doring, D. Dorn, U. Bachfischer, S. Amasheh, M. Herget, and H. Daniel. Functional analysis of a chimeric mammalian peptide transporter derived from the intestinal and renal isoforms. J. Physiol. 497:773-9 (1996).
77. 6/peptide cotransporter. FASEB J. 9:1489-96 (1995).
78. C. Boyd, J. R. Bronk, and P. A. Helliwell. Stereospecificity of dipeptide transport in rat lung in situ. J. Physiol. (Lond.) 467:187P (1993).
79. D. Meredith and C. A. Boyd. Dipeptide transport characteristics of the apical membrane of rat lung type II pneumocytes. Am. J. Physiol. 269:L137-43 (1995).
80. P. A. Helliwell, D. Meredith, C. A. R. Boyd, J. R. Bronk, N. Lister, and P. D. Bailey. Tripeptide transport in rat lung. Biochim. Biophys. Acta 1190:430-4 (1994).
81. K. Morimoto, H. Yamahara, V. H. L. Lee, and K. J. Kim. Dipeptide transport across rat alveolar epithelial cell monolayers. Pharm. Res. 10:1668-74 (1993).
82. H. Wang, Y. J. Fei, V. Ganapathy, and F. H. Leibach. Electrophysiological characteristics of the proton-coupled peptide transporter PEPT2 cloned from rat brain. Am. J. Physiol. 275:C967-75 (1998).
83. S. T. Dieck, H. Heuer, J. Ehrchen, C. Otto, and K. Bauer. The peptide transporter PepT2 is expressed in rat brain and mediates the accumulation of the fluorescent dipeptide derivative beta-Ala-Lys-N-epsilon-AMCA in astrocytes. Glia 25:10-20 (1999).
84. T. Yamashita, S. Shimada, W. Guo, K. Sato, E. Kohmura, T. Hayakawa, T. Takagi, and M. Tohyama. Cloning and functional expression of a brain peptide/histidine transporter. J. Biol. Chem. 272:10205-11 (1997).
85. W. B. Frommer, S. Hummel, and D. Rentsch. Cloning of an Arabidopsis histidine transporting protein related to nitrate and peptide transporters. FEBS Lett. 347:185-9 (1994).
86. D. Rentsch, M. Laloi, I. Rouhara, E. Schmelzer, S. Delrot, and W. B. Frommer. NTR1 encodes a high affinity oligopeptide transporter in Arabidopsis. FEBS Lett. 370:264-8 (1995).
87. M. Vatish, D. Meredith, N. A. Reid, and N. Eleno. Peptide transport in human placental membrane vesicles. J. Physiol. 459:173P (1992).
88. Ganapathy and F. H. Leibach. Is intestinal peptide transport energized by a proton gradient? Am. J. Physiol. 249:G153-60 (1985).
89. D. Meredith and R. W. Laynes. Dipeptide transport in brush-border membrane vesicles (BBMV) prepared from human full-term placentae. Placenta 17:173-9 (1996).
90. R. C. Sharma, S. Inoue, J. Roitelman, R. T. Schimke, and R. D. Simon. Peptide transport by the multidrug resistance pump. J. Biol. Chem. 267:5731-4 (1992).
91. B. Sarkadi, M. Muller, and Z. Hollo. The multidrug transporters - proteins of an ancient immune system. Immunol. Lett. 54 (1996).
92. S. Ruetz, M. Brault, W. Dalton, and P. Gros. Functional interactions between synthetic alkyl phospholipids and the ABC transporters P-glycoprotein, Ste-6, MRP, and Pgh 1. Biochemistry 36:8180-8 (1997).
93. M. D. Manson, V. Blank, G. Blade, and C. F. Higgins. Peptide chemotaxis in E. coli involves the Tap signal transducer and the dipeptide permease. Nature 321:253-6 (1986).
94. I. D. Hiles, L. M. Powell, and C. F. Higgins. Peptide transport in Salmonella typhimurium: molecular cloning and characterization of the oligopeptide permease genes. Mol. Gen. Genet. 206:101-9 (1987).
95. I. D. Hiles and C. F. Higgins. Peptide uptake by Salmonella typhimurium. The periplasmic oligopoptide-binding protein. Eur. J. Biochem. 158:561-7 (1986).
96. M. Perego, C. F. Higgins, S. R. Pearce, M. P. Gallagher, and J. A. Hoch. The oligopeptide transport system of Bacillus subtilis plays a role in the initiation of sporulation. Mol. Microbiol. 5:173-85 (1991).
97. C. Mathiopoulos, J. P. Mueller, F. J. Slack, C. G. Murphy, S. Patankar, G. Bukusoglu, and A. L. Sonenshein. A Bacillus subtilis dipeptide transport system expressed early during sporulation. Mol. Microbiol. 5:1903-13 (1991).
98. G. Alloning, M. C. Trombe, and J. P. Claverys. The ami locus of the gram-positive bacterium Streptococcus pneumoniae is similar to binding protein-dependent transport operons of gram-negative bacteria. Mol. Microbiol. 4:633-44. (1990).
99. E. R. Kunji, E. J. Smid, R. Plapp, B. Poolman, and W. N. Konings. Di-tripeptides and oligopeptides are taken up via distinct transport mechanisms in Lactococcus lactis. J. Bacteriol. 175:2052-9 (1993).
100. D. Z. Rudner, J. R. LeDeaux, K. Ireton, and A. D. Grossman. The spo0K locus of Bacillus subtilis is homologous to the oligopeptide permease locus and is required for sporulation and competence. J. Bacteriol. 173:1388-98 (1991).
101. Steiner, Henry-York, F. Naider, and J. M. Becker. The PTR family: a new group of peptide transporters. Mol. Microbiol. 16: 825-34 (1995).
102. 6)-dependent oligopeptide transporter family PTR: inferences on structure and function of the intestinal PEPT1 transporter. Pharm. Res. 14:388-400 (1997).
103. I. T. Paulsen and R. A. Sieurray. The POT family of transport proteins. Trends Biochem. Sci 19:404 (1994).
104. 6peptide cotransporter. Cloning, functional expression, and chromosomal localization. J. Biol. Chem. 270:6456-63 (1995).
105. H. Y. Steiner, W. Song, L. Zhang, F. Naider, J. M. Becker, and G. Stacey. An Arabidopsis peptide transporter is a member of a new class of membrane transport proteins. Plant Cell 6:1289-99 (1994).
106. N. C. Huang, C. S. Chiang, N. M. Crawford, and Y. F. Tsay. CHLI encodes a component of the low-affinity nitrate uptake system in Arabidopsis and shows cell type-specific expression in roots. Plant Cell 8:2183-91 (1996).
107. J. R. Perry, M. A. Basrai, H.-Y. Steiner, F. Naider, and J. M. Becker. Isolation and characterization of a Saccharomyces cerevisiae peptide transporter gene. Mol. Cell Biol. 14:104-15 (1994).
108. M. A. Basrai, M. A. Lubkowitz, J. R. Perry, D. Miller, E. Krainer, F. Naider, and J. M. Becker. Cloning of a Candida albicans peptide transport gene. Microbiology 141:1147-56 (1995).
109. A. Hagting, E. R. Kunji, K. J. Leenhouts, B. Poolman, and W. N. Konings. The di-and tripeptide transport protein of Lactococcus lactis. A new type of bacterial peptide transporter. J. Biol. Chem. 269:11391-9 (1994).
110. A. Hagting, J. Knol, B. Hasemeier, M. R. Streutker, G. Fang, B. Poolman, and W. N. Konings. Amplified expression, purification and functional reconstitution of the dipeptide and tripeptide transport protein of Lactococcus lactis. Eur. J. Biochem. 247:581-7 (1997).
111. A. Hagting, J. v.d. Velde, B. Poolman, and W. N. Konings. Membrane topology of the di- and tripeptide transport protein of Lactococcus lactis. Biochemistry 36:6777-85 (1997).
112. S. Beck, A. Kelly, E. Radley, F. Khurshid, R. P. Alderton, and J. Trowsdale. DNA sequence analysis of 66 kb of the human MHC class II region encoding a cluster of genes for antigen processing. J. Mol. Biol. 228:433-41 (1992).
113. W. N. Abouhamad, M. Manson, M. M. Gibson, and C. F. Higgins. Peptide transport and chemotaxis in Escherichia coli and Salmonella typhimurium: characterization of the dipeptide permease (Dpp) and the dipeptide-binding protein. Mol. Microbiol. 5:1035-47 (1991).
114. W. N. Abouhamad and M. D. Manson. The dipeptide permease of Escherichia coli closely resembles other bacterial transport systems and shows growth-phase-dependent expression. Mol. Microbiol. 14:1077-92 (1994).
115. K. Kashiwagi, Y. Yamaguchi, Y. Sakai, H. Kobayashi, and K. Igarashi. Identification of the polyamine-induced protein as a periplasmic oligopeptide binding protein. J. Biol. Chem. 265:8387-91 (1990).
116. S. Tynkkynen, G. Buist, E. Kunji, J. Kok, B. Poolman, G. Venema, and A. Haandrikman. Genetic and biochemical characterization of the oligopeptide transport system of Lactococcus lactis. J. Bacteriol. 175:7523-32 (1993).
117. I. D. Hiles, M. P. Gallagher, D. J. Jamieson, and C. F. Higgins. Molecular characterization of the oligopeptide permease of Salmonella typhimurium. J. Mol. Biol. 195:125-42 (1987).
118. J. P. F. Bai and G. L. Amidon. Structural specificity of mucosal-cell transport and metabolism of peptide drugs: Implication for oral peptide drug delivery. Pharm. Res. 9:969-78 (1992).